← back to search

Hao Yuan

Harbin Medical University · CN
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include RNA modifications and cancer, Circular RNAs in diseases, Cancer-related molecular mechanisms research, and Pancreatic and Hepatic Oncology Research.
h-index
31
citations
8,684
works
80
NIH funding
primary concept
Biology
email

Recent publications

Mitochondrial Genome‐Encoded <scp>lncND5</scp> Regulates Mitophagy in Hypoxic Pulmonary Artery Smooth Muscle Cell
The FASEB Journal 2025cited by 4position: middledoi
Identification of miRNA-TF Regulatory Pathways Related to Diseases from a Neuroendocrine-Immune Perspective
Cellular and Molecular Neurobiology 2024cited by 1position: middledoi
KEAP1 mutation in lung adenocarcinoma promotes immune evasion and immunotherapy resistance
Cell Reports 2023cited by 124position: middledoi
Single‐cell analysis of localized prostate cancer patients links high Gleason score with an immunosuppressive profile
The Prostate 2023cited by 15position: middledoi
KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition
Cancer Cell 2022cited by 94position: middledoi
Ubiquitinated AIF is a major mediator of hypoxia-induced mitochondrial dysfunction and pulmonary artery smooth muscle cell proliferation
Cell & Bioscience 2022cited by 40position: middledoi
LncND5 encoded by mitochondrial genomes regulating mitochondrial autophagy via activation of complex Ⅰ and binding to HMGCS1
Research Square 2022cited by 1position: middledoi
Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer
Clinical Cancer Research 2021cited by 272position: middledoi
Time-ordered dysregulated ceRNA networks reveal disease progression and diagnostic biomarkers in ischemic and dilated cardiomyopathy
Cell Death Discovery 2021cited by 5position: middledoi
Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors
Cell Host & Microbe 2020cited by 170position: middledoi
SOAT1 promotes mevalonate pathway dependency in pancreatic cancer
The Journal of Experimental Medicine 2020cited by 130position: middledoi
ALKBH5 Inhibits Pancreatic Cancer Motility by Decreasing Long Non-Coding RNA KCNK15-AS1 Methylation
Cellular Physiology and Biochemistry 2018cited by 294position: middledoi
NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer
Cell 2016cited by 380position: middledoi
Adaptation to AI Therapy in Breast Cancer Can Induce Dynamic Alterations in ER Activity Resulting in Estrogen-Independent Metastatic Tumors
Clinical Cancer Research 2016cited by 31position: middledoi
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
Cell 2014cited by 2,154position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Cui Ma · Fudan University3 papers (2022–2025)Jian Mei · Kunming University of Science and Technology3 papers (2022–2025)June Bai · Harbin Medical University3 papers (2022–2025)Lixin Zhang · Oldham Council2 papers (2022–2022)Hongbo Shi · Ningbo University2 papers (2021–2024)Siyu He · Guiyang Medical University2 papers (2022–2025)Xiaoyu Guan · Harbin Medical University2 papers (2022–2022)Scott W. Lowe · Memorial Sloan Kettering Cancer Center2 papers (2020–2020)Francisco J. Sánchez‐Rivera · Howard Hughes Medical Institute2 papers (2020–2020)Danni Gao · Harbin Medical University2 papers (2022–2025)Guangde Zhang · Harbin Medical University2 papers (2021–2024)Daling Zhu · Ministry of Education of the People's Republic of China2 papers (2022–2022)Xiangrui Zhu · Harbin Medical University2 papers (2022–2022)Judy Zhong · NYU Langone Health1 papers (2023–2023)Ziyang Wang · Sun Yat-sen University1 papers (2024–2024)Lloyd C. Trotman · Stony Brook University1 papers (2020–2020) · 1 papers (2020–2020)Yingli Lv · Harbin Medical University1 papers (2024–2024)Damir Varešlija · University College Dublin1 papers (2016–2016)Johannes Zuber · Research Institute of Molecular Pathology1 papers (2020–2020)